Coronavirus: Three Indian pharmaceuticals to supply Remdesivir to Nepal

Soon, Indian pharmaceutical companies would begin supply of Remdesivir, a life-saving, anti-viral drug that is used for treating COVID-19 patients. 

"We have confirmed three companies for supply of Remdesivir. Mylan, Cipla, and Hetero Drugs will be supplying drugs as per demands. We will be permitting use of anti-viral supplied on by se companies only," said Narayan Pras Dhakal, Director-General of Department of Drug ministration confirmed.

Narayan Pras Dhakal, Director-General, Department of Drug ministration h confirmed that "Mylan, Cipla, and Hetero Drugs would supply drug as per demand of ministry". 

Re | EU approves use of remdesivir to treat severe cases of coronavirus

"One of establishments has alrey started supply of drug to Himalayan Country," furr ded Dhakal. 

Remdesivir has been proved to be efficient for patients who have been put in Intensive Care Unit and take m out of danger zone but wasn't available in Himalayan nation.

drug h been found effective for patients, who were earlier being treated in Intensive Care Unit(ICU), by European Union(EU) in early July. cases were primarily those who needed more oxygen. However, it was t available in Nepal reily. 

Re | Zydus Cila launches COVID-19 drug Remdesivir in India

"It would cost around 7,800 Nepali rupees per vial when it comes to Nepali market. supply of drug by India would help to save in extra expenses of families," furr ded DG Dhakal. 

drug also h been enlisted by Medical Council of Nepal for primary medication. 

"India pharma companies have always been at forefront of exporting drugs and or pharma needs of ours," said DG of Department of Drug ministration, Government of Nepal. 

At present, more than 62 companies from India have been given permission to import medicines from or nations.

Re | UK’s Hikma starts manufacturing remdesivir for Gile for COVID-19 treatment

As of Friday, total of active cases in Nepal was 29,645, and h claimed lives of almost 126 people. 

What exactly is Remdesivir ? 

drug, Remdesivir, which h been found effective in treatment of Ebola has again me news since it was found to be effective against treatment of COVID-19, which was caused due to SARS-CoV-19. In month of May, drug h recieved "Emergency Use Authorization" by USFDA. At present, drug is in third phase of clinical trials for treating ults infected with Coronavirus. 

(With Inputs From ANI)

(Im Credits;ANI)